India Pharma Outlook Team | Monday, 15 June 2026
.jpg "Maharashtra FDA Cracks Down on Hospital Pharmacy Monopoly")
The Maharashtra FDA has brought major relief to patients across the state with hospital pharmacy monopoly crackdown.
In a fresh directive, the Maharashtra Food and Drug Administration (FDA) has instructed hospitals, doctors, and hospital-linked pharmacies not to force patients to purchase medicines exclusively from in-house medical stores.
The move aims to protect patient rights and ensure fair access to medicines at competitive prices. The movement comes after the regulator received complaints that some hospitals were pressuring patients and their families to buy prescribed medicines only from pharmacies operating within hospital premises. According to the FDA, such practices restrict patient choice and may lead to higher medicine costs.
The Maharashtra FDA has clarified that patients are free to buy medicines from any licensed pharmacy of their choice. Hospitals cannot make treatment, admission, discharge, or access to prescribed medicines dependent on purchases from hospital-owned or affiliated pharmacies.
The regulator emphasized that patients should not face any inconvenience or discrimination if they choose to purchase medicines from outside pharmacies.
Key highlights of the directive include:
The FDA's action is expected to increase competition among pharmacies and help patients access medicines at better prices.
Also Read: The Evolving Role of India as a Talent Hub for Healthcare R&D
The latest directive follows complaints received by the Maharashtra FDA regarding hospitals allegedly compelling patients to buy medicines only from hospital-attached pharmacies. Such practices raised concerns about monopolistic behavior and limited consumer choice.
Officials noted that patients often find medicines at lower prices outside hospital premises due to discounts, generic alternatives, and competitive pricing. Restricting purchases to a single pharmacy can increase the financial burden on families, especially during medical emergencies and long-term treatments.
By issuing the directive, the FDA has reinforced the principle that healthcare providers should focus on patient care rather than influencing purchasing decisions.
The recent order is not an entirely new regulation. The Maharashtra FDA had previously issued similar instructions in 2016 and again in 2022, reminding hospitals that they cannot compel patients to buy medicines from specific pharmacies.
However, recurring complaints prompted the regulator to reiterate the rules and strengthen enforcement efforts. The FDA has indicated that hospitals and pharmacies violating the directive could face regulatory scrutiny and action under applicable laws.
Healthcare experts believe the move will improve transparency in the healthcare system while empowering patients to make informed purchasing decisions.
If a hospital insists on purchasing medicines only from its pharmacy, patients can:
The directive is expected to benefit thousands of patients by ensuring greater freedom of choice and helping them manage healthcare expenses more effectively.
.jpg)
